Analysis of the current state of the pharmaceutical market of the Republic of Kazakhstan

Authors

DOI:

https://doi.org/10.15587/2519-4852.2023.267787

Keywords:

pharmacy, pharmaceutical market, medical preparations, medical products, pharmaceutical production, SK-Pharmacy, SWOT analysis, questionnaire, strategic matrix, Republic of Kazakhstan

Abstract

This article analyses the current state of the pharmaceutical market of the Republic of Kazakhstan for the period 2015-2021 and diagnoses the current problems of pharmaceutical production.

The aim: to identify the current trends of the pharmaceutical market in the Republic of Kazakhstan, its specific features and prospects for the development of domestic pharmaceutical production.

Materials and methods: statistical data, survey results, mathematical-statistical and analytical comparative methods, SWOT analysis.

Research results: according to the results of statistical analysis, pharmaceutical production increased by 101.1 billion tenges in monetary terms compared to 2015, and the export of domestic products increased by 13.3 billion tenges. In 2020, the export of medical preparations due to supplies to Russia amounted to 76.5 %, to Kyrgyzstan 6.5 % and Uzbekistan 4.8 %, to other countries - 12.3 %. It is estimated that the volume of the pharmaceutical market of the Republic of Kazakhstan in 2020, compared with 2019, increased by 21.3 % as a result of the development of domestic production and the implementation of the state support program. The total number of medicines registered in the republic is 7449, and the share of domestic production is 13.1 % (978 medical preparations), and 6471 medicines, 86.9 %, are imported. In addition, 9154 medical devices have been registered, and the share of domestic products is 90 %.

Online direct expert survey (questionnaire) indicates that the respondents are female pharmacists (74.5 %) aged 36 to 55 years old (52.3 %) with 26-30 years of work experience (32.3 %), who noted the strengths of the development of the pharmaceutical industry in Kazakhstan (U=1.35), as readiness for modernisation and state support (47 %), political stability (44 %), weaknesses (U=1.35) - insignificant capacity of the pharmaceutical market (55.5 %), limited range of domestic pharmaceutical products and substances (50.9 %), opportunities (U=1.4) - active investment policy (62.7 %), expansion of digital and remote channels (25.4 %), threats (U=1.4) – import dependence (69.9 %), high volatility of the tenge exchange rate (24.1 %).

Based on the pharmaceutical market analysis and expert survey of specialists, a strategic matrix of SWOT analysis was built.

Conclusion. As a result of the analysis, the dependence of the pharmaceutical industry and the pharmaceutical market on imported foreign medicines and substances were revealed. However, the volume of pharmaceutical products produced in the Republic of Kazakhstan increases annually. Therefore, for the further development of the pharmaceutical industry of the Republic of Kazakhstan, considering its import dependence, additional funding is needed for research and educational activities for the development of innovative medical preparations and substances

Author Biographies

Kairat Zhakipbekov, S. D. Asfendiyarov Kazakh National Medical University

PhD, Associate Professor

School of Pharmacy

Olga Posylkina , National University of Pharmacy

Doctor of Pharmaceutical Sciences, Professor

Department of Management and Quality Assurance in Pharmacy

Narbek Zhumabayev , South Kazakhstan Medical Academy

Candidate of Pharmaceutical Sciences, docent

School of Pharmacy

Ubaidilla Datkhayev, S. D. Asfendiyarov Kazakh National Medical University

Doctor of Pharmaceutical Sciences, Professor

School of Pharmacy

Nurdaulet Zhumabayev, S. D. Asfendiyarov Kazakh National Medical University

School of Pharmacy

Almira Almurzaeva, S. D. Asfendiyarov Kazakh National Medical University

School of Pharmacy

Arailym Mukanova, S. D. Asfendiyarov Kazakh National Medical University

School of Pharmacy

References

  1. Korzh, I., Olieinikova, N., Beketova, M., Kubarieva, I., Korobova, Y., Sevriukov, O., Afanasenko, O. (2022). Comparative analysis of drug consumption for the treatment of epilepsy in Ukraine, Kazakhstan and Belarus. ScienceRise: Pharmaceutical Science, 2 (36), 26–36. doi: https://doi.org/10.15587/2519-4852.2022.255840
  2. Almurzayeva, A., Zhakipbekov, K., Ashirov, M. (2022). Competitiveness of the pharmaceutical industry of Kazakhstan. European Journal of Clinical Pharmacology, 78 (1), S87–S87.
  3. Tereshchenko, L., Zhirova, I. (2019). Analysis of the dynamics of expenditures on pharmaceutical support of population in Ukraine, Belarus republic and in European Union. ScienceRise: Pharmaceutical Science, 4 (20), 10–14. doi: https://doi.org/10.15587/2519-4852.2019.177193
  4. Datkhayev, U., Shopabaeva, A., Zhakipbekov, K., Shertaeva, C., Umurzakhova, G., Sultanbekov, A. et al. (2016). Determination of seasonal demand for pharmaceutical staff. International Journal of Pharmaceutical Sciences Review and Research, 36 (2), 105–111. Available at: https://globalresearchonline.net/journalcontents/v36-2/18.pdf
  5. Umurzakhova, G., Zhakipbekov, K., Sultanbekov, A., Tulemissov, S., Dilbarkhanov, B., Sapakbay, M., Datkhayev, U. (2017). Analyzing the Ways to Improve Personnel Management in the Pharmaceutical Industry of Kazakhstan. Journal of Global Pharma Technology, 9 (11), 223–237.
  6. Zhakipbekov, K., Umurzakhova, G., Sultanbekov, A., Issatayeva, N., Shopabaeva, A., Shertaeva, C., Datkhayev, U. (2018). Communication skills as one of the main competences of pharmacists. Annals of Tropical Medicine and Public Health, 11 (3), 62. https://doi.org/10.4103/atmph.atmph_194_17
  7. Serikbayeva, E. A., Zhakipbekov, K. S., Umurzakhova, G. Zh., Datkhayev, U. M., Kauypova, F. E., Dyusembinova, G. A. (2020). Methods of Assessing the Possibility of Forming a Branch Regional Clusters in RK. Systematic Reviews in Pharmacy, 11 (6), 425–434. Available at: https://www.sysrevpharm.org/articles/methods-of-assessing-the-possibility-of-forming-a-branch-regional-clusters-in-rk.pdf
  8. Shertaeva, C., Tulemissov, S., Botabayeva, R., Blinova, O., Mamytbayeva, K., Zhanabayev, N., Ibragimov, G., Datkhayev, U., Zhakipbekov, K. (2014). Improvement of medicine provision of patients with a chronic obstructive lung illness on the basis of pharmaceutical and economical investigations. Life Science Journal, 11 (9s), 16–23.
  9. Li, Z., Li, X. (2021). Will Innovation of Pharmaceutical Manufacturing Improve Perceived Health? Frontiers in Public Health, 9. doi: https://doi.org/10.3389/fpubh.2021.647357
  10. Datkhayev, U. M., Sakipova, Z. B., Ustenova, G. O., Zhakipbekov, K. S., Kozhanova, K. K., Kapsalyamova, E. N. et al. (2019). Validation of Spectrophotometric Method for Determination of Thiamazole in Liquids by Dissolution Test for the Transdermal Form. Pharmaceutical Chemistry Journal, 53 (6), 572–576. doi: https://doi.org/10.1007/s11094-019-02039-3
  11. Ashirov, M. Z., Datkhayev, U. M., Myrzakozha, D. A., Sato, H., Zhakipbekov, K. S., Rakhymbayev, N. A., Sadykov, B. N. (2020). Study of Cold-Pressed Tobacco Seed Oil Properties by Gas Chromatography Method. The Scientific World Journal, 2020, 1–5. doi: https://doi.org/10.1155/2020/8852724
  12. Turgumbayeva, A., Ustenova, G., Datkhayev, U., Rahimov, K., Abramavicius, S., Tunaityte, A. et al. (2020). Safflower (Carthamus Tinctorius L.) a Potential Source of Drugs against Cryptococcal Infections, Malaria and Leishmaniasis. Phyton, 89 (1), 137–146. doi: https://doi.org/10.32604/phyton.2020.07665
  13. Tleubayeva, M. I., Abdullabekova, R. M., Datkhayev, U. М., Ishmuratova, M. Yu., Alimzhanova, M. B., Kozhanova, K. K. et al. (2022). Investigation of CO2 Extract of Portulaca oleracea for Antioxidant Activity from Raw Material Cultivated in Kazakhstan. International Journal of Biomaterials, 2022, 1–11. doi: https://doi.org/10.1155/2022/6478977
  14. Turgumbayeva, A., Tileuberdi, N., Zhakipbekov, K., Tulemissov, S., Umurzakhova, G., Utegenova, G. (2021). Antimicrobial efficacies of Brassica Napus L. essential oils/ nanoparticles composites. Journal of Nanostructures, 11 (3), 524–533. doi: https://doi.org/10.22052/JNS.2021.03.010
  15. Turgumbayeva, A., Zhakipbekov, K., Shimirova, Z., Akhelova, S., Amirkhanova, A., Koilybayeva, M. et al. (2022). Study of phytochemical compounds of Plantago major leaves grown in Kazakhstan. Pharmacia, 69 (4), 1019–1026. doi: https://doi.org/10.3897/pharmacia.69.e96526
  16. Akhmetov, S. M. (Ed.) (2014). Tekhnicheskie i sotcialno-ekonomicheskie problemy: effektivnye puti ikh resheniia. Novosibirsk: SibAK Publishing House, 198.
  17. Bespereboinoe obespechenie LS i MI v postpandemicheskii period: godovoi otchet TOO «SK-Farmatciia» za 2021 god (2022). Nur-Sultan: SK-Pharmacy LLP, 44. Available at: https://sk-pharmacy.kz/rus/about/otchetnost
  18. Itogi farmatcevticheskogo rynka GLS za 2020 god (2021). Kazakhstanskii Farmatcevticheskii Vestnik, 4 (603). Available at: https://pharmnewskz.com/ru/analytic/itogi-farmacevticheskogo-rynka-gls-za-2020-god_17876
  19. On Public Health and Healthcare system (2020). Code of the Republic of Kazakhstan No. 360-VI. 07.07.2020 ZRK. Available at: https://adilet.zan.kz/kaz/docs/K2000000360
  20. Farmpromyshlennost RK: obemy, potrebnosti i obespechennost (2021). Available at: https://qazindustry.gov.kz/ru/article/1986-rynok-farmatsevticheskoy-produktsii-i-otechestvennykh-lekarstvennykh-preparatov Last accessed: 12.03.2021
  21. Rynok farmatcevticheskoi produktcii i otechestvennykh lekarstvennykh preparatov (2021). Available at: https://qazindustry.gov.kz/ru/article/1986-rynok-farmatsevticheskoy-produktsii-i-otechestvennykh-lekarstvennykh-preparatov Last accessed: 08.10.2021
  22. Sozdavaia ravnuiu i svoevremennuiu dostupnost LS i MI v uvtoviiakh pandemii (2020). Otchet tovarishchestva s ogranichennoi otvetstvennostiu «SK-FARMATcIIa» po itogam 2020 goda. https://sk-pharmacy.kz/files4/%D0%9D%D0%B0%D1%80%D0%BE%D0%B4%D0%BD%D1%8B%D0%B9%20%D0%BA%D0%BE%D0%BD%D1%82%D1%80%D0%BE%D0%BB%D1%8C/%D0%93%D0%BE%D0%B4%D0%BE%D0%B2%D0%BE%D0%B9%20%D0%BE%D1%82%D1%87%D0%B5%D1%82%20%D0%95%D0%94%20%D0%B7%D0%B0%202020%20%D0%B3%D0%BE%D0%B4.pdf Last accessed: 15.07.2022.
  23. Podderzhka otechestvennykh proizvoditelei. Available at: https://sk-pharmacy.kz/rus/sotrudnichestvo/podderzhka_otech_proizvoditele/ Last accessed: 15.07.2022
  24. Arutyunova, D. V. (2010). Strategicheskii menedzhment. Taganrog: Izd-vo TTI IuFU, 122. Available at: http://www.aup.ru/books/m205/
  25. Moroz, S., Sahaidak-Nikitiuk, R., Zoidze, D. (2019). Implementation of the Quantitative SWOT Analysis Method in the Research on the Contemporary State and Prospects of Consistent Development of the Pharmaceutical Branch. Research Journal of Pharmacy and Technology, 12 (11), 5199–5205. doi: https://doi.org/10.5958/0974-360x.2019.00900.4
  26. Mamedyarov, Z. (2018). Pharmaceutical sector in Iran: current status and prospecs. World Economy and International Relations, 62 (7), 57–62. doi: https://doi.org/10.20542/0131-2227-2018-62-7-57-62
  27. Tare, S., Bageria, S. (2019). SWOT analysis of indian pharmaceutical industry: in referance to indian sme pharma industry approchestowards competitive advantage. International Journal of Innovation in Engineering Research & Management, 6 (1).
  28. Tashenov, A., Cherednichenko, N. (2013). Development Prospects for the Pharmaceutical Market of the Single Economic Space. Eurasian Development Bank, Sector Report No. 18. Available at: https://ssrn.com/abstract=4109101
Analysis of the current state of the pharmaceutical market of the Republic of Kazakhstan

Downloads

Published

2023-04-30

How to Cite

Zhakipbekov, K., Posylkina , O., Zhumabayev , N., Datkhayev, U., Zhumabayev, N., Almurzaeva, . A., & Mukanova, A. (2023). Analysis of the current state of the pharmaceutical market of the Republic of Kazakhstan. ScienceRise: Pharmaceutical Science, (2(42), 57–67. https://doi.org/10.15587/2519-4852.2023.267787

Issue

No. 2(42) (2023)

Section

Pharmaceutical Science

License

Copyright (c) 2023 Kairat Zhakipbekov, Olga Posylkina , Narbek Zhumabayev , Ubaidilla Datkhayev, Nurdaulet Zhumabayev, Almira Almurzaeva, Arailym Mukanova

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.